Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.740
-0.110 (-3.86%)
Aug 1, 2025, 4:00 PM - Market closed

Blueprint Medicines Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
5317155234537
Upgrade
Market Cap Growth
-91.88%-82.04%-89.08%-33.56%-56.40%-36.65%
Upgrade
Enterprise Value
516143172404
Upgrade
Last Close Price
2.741.9110.6097.36163.50378.00
Upgrade
PS Ratio
492.76305.043396.2853.20587.82-
Upgrade
PB Ratio
4.151.482.694.034.034.33
Upgrade
P/TBV Ratio
5.121.482.694.034.034.33
Upgrade
EV/Sales Ratio
463.76136.741241.6849.00431.80-
Upgrade
Debt / Equity Ratio
---0.510.510.04
Upgrade
Asset Turnover
0.000.0000.040.00-
Upgrade
Quick Ratio
0.301.583.101.624.816.52
Upgrade
Current Ratio
1.003.984.222.234.917.11
Upgrade
Return on Equity (ROE)
-139.03%-111.80%-156.66%-78.11%-86.52%-73.04%
Upgrade
Return on Assets (ROA)
-63.78%-54.59%-48.66%-25.61%-37.91%-39.32%
Upgrade
Return on Capital (ROIC)
-88.86%-71.86%-55.33%-28.13%-42.29%-44.42%
Upgrade
Earnings Yield
-75.09%-153.39%-206.93%-24.27%-33.66%-14.90%
Upgrade
FCF Yield
-70.59%-162.96%-178.66%-18.95%-27.69%-12.45%
Upgrade
Buyback Yield / Dilution
-0.05%-0.11%-10.50%-1.27%-2.27%-24.82%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q